Dr. Reddy’s Lab launches Atomoxetine Capsules in US market
Dr. Reddy’s Laboratories has launched Atomoxetine Capsules, USP, a therapeutic equivalent generic version of Strattera (atomoxetine) Capsules in the United States market approved by the US Food and Drug Administration (USFDA). The Strattera brand and generic had US sales of approximately $304 million MAT for the most recent twelve months ending in August 2018 according … Read more



